Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gram-negative septicemia and shock

C P Craig

    Comprehensive Therapy
    |February 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Gram-negative septicemia management has evolved, requiring broad practitioner understanding. Future success hinges on targeted immunotherapies, antibiotics, and pharmacotherapies, moving beyond nonspecific treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS.

    AIDS (London, England)·1998
    Same author

    Impact of dressing materials on central venous catheter infection rates.

    Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·1997
    Same author

    Vancomycin-resistant Staphylococcus aureus.

    Annals of internal medicine·1996
    Same author

    Isolated tricuspid valve endocarditis due to Streptococcus bovis.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1996
    Same author

    Nosocomial transmission of tuberculosis.

    Annals of internal medicine·1995
    Same author

    Spontaneous bacterial peritonitis due to Corynebacterium xerosis.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1993
    Same journal

    Heparin-induced thrombocytopenia and thrombosis.

    Comprehensive therapy·2011
    Same journal

    Antiplatelet therapy in cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Genetics of cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Septic renal vein thrombosis complicated by septic pulmonary embolism.

    Comprehensive therapy·2011
    Same journal

    Gout and hyperuricemia.

    Comprehensive therapy·2011
    Same journal

    Problems with computerized health records.

    Comprehensive therapy·2011
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Immunology
    • Pharmacology

    Background:

    • Gram-negative septicemia, a long-standing condition, has seen significant evolution in its medical management.
    • Historically managed by specialists, it now requires comprehensive understanding across various medical practice areas.
    • The intricate relationship between sepsis and underlying host diseases is a critical factor in patient outcomes.

    Purpose of the Study:

    • To highlight the evolving landscape of Gram-negative septicemia treatment.
    • To emphasize the need for broad practitioner understanding of this condition.
    • To explore promising future therapeutic strategies beyond current nonspecific approaches.

    Main Methods:

    • Review of the current understanding of septicemia physiology and host responses.

    Related Experiment Videos

  • Analysis of the historical and contemporary management paradigms for Gram-negative septicemia.
  • Evaluation of the potential impact of novel therapeutic modalities.

    • Main Results:

    • Gram-negative septicemia is now managed across a wider range of medical specialties.
    • A deeper understanding of septicemia physiology and host interactions is emerging.
    • Nonspecific therapies remain crucial for initial management of septicemia and shock.

    Conclusions:

    • Effective management of Gram-negative septicemia necessitates broad medical practitioner engagement.
    • Specific immunotherapies, including antibodies and vaccines, represent a promising frontier.
    • Targeted antibiotic selection and pharmacotherapy addressing host response mediators offer the greatest potential for successful outcomes.